Etomidate Solution
Product Images NDC 68083-235

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Etomidate (NDC 68083-235). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Etomidate-10ml-container (Etomidate 10ml Container)

Label for Etomidate Injection, USP 20 mg/10 mL (2 mg/mL), an intravenous sterile, non-pyrogenic solution in a 10 mL single-dose vial. Manufactured by Gland Pharma Limited, India, with storage instructions and barcode visible.*

FDA Label Image

Etomidate-20ml-container (Etomidate 20ml Container)

Label for Etomidate Injection, USP 40 mg/20 mL (2 mg/mL) solution for intravenous use. The label states it is a sterile, non-pyrogenic, single-dose vial containing 20 mL. Manufactured by Gland Pharma Limited, India. The label includes usage directions, storage instructions, a barcode, and space for lot and expiration dates.*

FDA Label Image

Etomidate-structure (Etomidate Structure)

Chemical structure diagram of Etomidate, the active ingredient in Etomidate Injection. The diagram shows atoms and bonds characteristic of the molecule, including an imidazole ring and ester functional group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.